These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1325217)

  • 1. Immunohistochemical markers in the identification of metastatic breast cancer.
    de Almeida PC; Pestana CB
    Breast Cancer Res Treat; 1992; 21(3):201-10. PubMed ID: 1325217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
    Monteagudo C; Merino MJ; LaPorte N; Neumann RD
    Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast epithelial antigen levels and breast tumor antigen content.
    Ceriani RL; Chan C
    Breast Cancer Res Treat; 1990 Nov; 17(1):55-8. PubMed ID: 2095928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma.
    Hitchcock A; Ellis IO; Robertson JF; Gilmour A; Bell J; Elston CW; Blamey RW
    J Pathol; 1989 Oct; 159(2):129-34. PubMed ID: 2553906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
    Brown RW; Campagna LB; Dunn JK; Cagle PT
    Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
    Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
    Yang Y; Lu S; Zeng W; Xie S; Xiao S
    Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.
    Ciocca DR; Luque EH
    Breast Cancer Res Treat; 1991 Dec; 20(1):33-42. PubMed ID: 1667487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.
    Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
    Chia SY; Thike AA; Cheok PY; Tan PH
    Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of neoplastic cells of breast origin.
    Noriega M; Paesani F; Perazzo F; Lago N; Krupitzki H; Nieto S; Garcia A; Avagnina A; Elsner B; Denninghoff VC;
    Diagn Pathol; 2012 Jun; 7():73. PubMed ID: 22726568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
    Dean CJ; Allan S; Eccles S; McFarlane C; Styles J; Valeri M; Sandle J; Bakir A; Sacks N
    Year Immunol; 1993; 7():182-92. PubMed ID: 8103950
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
    Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
    J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of two ovarian tumor-associated antigens in primary and metastatic breast, gastric, and colonic tumors.
    McGuckin MA; Wright RG; McKenzie IF; Ward BG
    Am J Clin Pathol; 1990 Aug; 94(2):137-41. PubMed ID: 2164766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR.
    Charpin C; Bonnier P; Khouzami A; Vacheret H; Andrac L; Lavaut MN; Allasia C; Piana L
    Anticancer Res; 1992; 12(3):591-7. PubMed ID: 1352440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An immunohistological study of monoclonal antibody BG6 against human breast cancer].
    Zhang SL
    Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):59-61. PubMed ID: 2550156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated antigens in breast carcinomas. Prognostic significance.
    Cohen C; Sharkey FE; Shulman G; Uthman EO; Budgeon LR
    Cancer; 1987 Sep; 60(6):1294-8. PubMed ID: 3040212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.